Affiliation:
1. The Life Raft Group, 155 US-46 Wayne, NJ 07470, United States
Abstract
Targeted treatment has become a major modality in cancer management. Such cancer drugs are generally designed to treat tumors with certain genetic/genomic makeups. Mutational testing prior to prescribing targeted therapy is crucial in identifying who can receive clinical benefit from specific cancer drugs. Over the last two decades, gastrointestinal stromal tumors (GISTs) have evolved from histogenetically obscure to being identified as distinct gastrointestinal mesenchymal tumors with well-defined clinical and molecular characteristics, for which multiple lines of targeted therapies are available. Although the National Comprehensive Cancer Network (NCCN) strongly recommends mutational testing for optimal management of GIST, many GIST patients still have neither a mutation test performed or any mutation-guided cancer management. Here, we review the mutation-guided landscape of GIST, mutational testing methods, and the recent development of new therapies targeting GIST with specific mutations.
Publisher
Bentham Science Publishers Ltd.
Subject
Cancer Research,Drug Discovery,Pharmacology,Oncology
Reference83 articles.
1. Duensing A.; Heinrich M.C.; Fletcher C.D.; Fletcher J.A.; Biology of gastrointestinal stromal tumors: KIT mutations and beyond. Cancer Invest 2004,22(1),106-116
2. Liegl-Atzwanger B.; Fletcher J.A.; Fletcher C.D.; Gastrointestinal stromal tumors. Virchows Arch 2010,456(2),111-127
3. Hirota S.; Isozaki K.; Moriyama Y.; Hashimoto K.; Nishida T.; Ishiguro S.; Kawano K.; Hanada M.; Kurata A.; Takeda M.; Muhammad Tunio G.; Matsuzawa Y.; Kanakura Y.; Shinomura Y.; Kitamura Y.; Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998,279(5350),577-580
4. Isozaki K.; Hirota S.; Miyagawa J.; Taniguchi M.; Shinomura Y.; Matsuzawa Y.; Deficiency of c-kit+ cells in patients with a myopathic form of chronic idiopathic intestinal pseudo-obstruction. Am J Gastroenterol 1997,92(2),332-334
5. Isozaki K.; Hirota S.; Nakama A.; Miyagawa J.; Shinomura Y.; Xu Z.; Nomura S.; Kitamura Y.; Disturbed intestinal movement, bile reflux to the stomach, and deficiency of c-kit-expressing cells in Ws/Ws mutant rats. Gastroenterology 1995,109(2),456-464
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献